Sunitinib Therapy for Melanoma Patients with KIT Mutations
DR Minor, M Kashani-Sabet, M Garrido, SJ O'Day… - Clinical cancer …, 2012 - AACR
Purpose: Recent studies have shown activating KIT mutations in melanoma originating from
mucosa, acral, or cumulative sun-damaged skin sites. We aimed to assess the predictive …
mucosa, acral, or cumulative sun-damaged skin sites. We aimed to assess the predictive …
The clinical significance of KIT mutations in melanoma: a meta-analysis
HZ Gong, HY Zheng, J Li - Melanoma research, 2018 - journals.lww.com
This study aimed to evaluate the association of KIT mutations with clinicopathologic features
of melanomas using a meta-analysis and to identify differences between Asian and White …
of melanomas using a meta-analysis and to identify differences between Asian and White …
KIT Gene Mutations and Copy Number in Melanoma Subtypes
C Beadling, E Jacobson-Dunlop, FS Hodi, C Le… - Clinical Cancer …, 2008 - AACR
Purpose: We recently identified a KIT exon 11 mutation in an anorectal melanoma of a
patient who had an excellent response to treatment with imatinib. To determine the …
patient who had an excellent response to treatment with imatinib. To determine the …
Targeting the HGF/MET Axis Counters Primary Resistance to KIT Inhibition in KIT-Mutant Melanoma
Activating mutations in KIT are present in up to 20% of acral melanomas (AMs) or mucosal
melanomas, and 5% of melanoma associated with chronic sun-damaged skin. 1-5 In GI …
melanomas, and 5% of melanoma associated with chronic sun-damaged skin. 1-5 In GI …
The MAPK pathway functions as a redundant survival signal that reinforces the PI3K cascade in c-Kit mutant melanoma
Stimulation of the c-Kit receptor tyrosine kinase has a critical role in the development and
migration of melanocytes, and oncogenic c-Kit mutants contribute to the progression of some …
migration of melanocytes, and oncogenic c-Kit mutants contribute to the progression of some …
[HTML][HTML] Multidisciplinary approach and treatment of acral and mucosal melanoma
A Fortuna, T Amaral - Frontiers in Oncology, 2024 - frontiersin.org
Acral and mucosal melanoma are uncommon variants of melanoma. Acral melanoma has
an age-adjusted incidence of approximately 1.8 cases per million individuals per year …
an age-adjusted incidence of approximately 1.8 cases per million individuals per year …
The mutational landscape of mucosal melanoma
KW Nassar, AC Tan - Seminars in cancer biology, 2020 - Elsevier
Mucosal melanoma is a rare and aggressive subtype of melanoma that has a less favorable
prognosis due to the lack of understanding and identification of oncogenic drivers. Recently …
prognosis due to the lack of understanding and identification of oncogenic drivers. Recently …
KIT amplification and gene mutations in acral/mucosal melanoma in Korea
Yun J, Lee J, Jang J, Lee EJ, Jang KT, Kim JH, Kim K‐M. KIT amplification and gene
mutations in acral/mucosal melanoma in Korea. APMIS 2011; 119: 330–5. Mucosal and …
mutations in acral/mucosal melanoma in Korea. APMIS 2011; 119: 330–5. Mucosal and …
NRAS and BRAF mutation frequency in primary oral mucosal melanoma
RR Buery, CH Siar, N Katase… - Oncology …, 2011 - spandidos-publications.com
Oral mucosal melanoma (OMM) is a fatal sarcoma of unknown etiology. Histological
morphology and genetic events are distinct from those of its cutaneous counterpart. Mutation …
morphology and genetic events are distinct from those of its cutaneous counterpart. Mutation …
Extensive vitiligo associated to response to c-kit inhibitor in metastatic mucosal melanoma
L Pala, F Conforti, E Cocorocchio… - Anti-Cancer Drugs, 2020 - journals.lww.com
Mucosal melanoma is rare and accounts for 1.3–1.4% of all melanomas. Kit mutations are
found in approximately 15–20% of mucosal melanomas. Immunotherapy with anti cytotoxic …
found in approximately 15–20% of mucosal melanomas. Immunotherapy with anti cytotoxic …